InsiderTrades.com logo

JAZZ Insider Trading

Insider Ownership Percentage: 4.30%
Insider Buying (Last 12 Months): $9,992,963.00
Insider Selling (Last 12 Months): $27,634,899.65

Jazz Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Jazz Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Jazz Pharmaceuticals Share Price & Price History

Current Price: $165.70
Price Change: ▼ Price Decrease of -1.141 (-0.68%)
As of 02/4/2026 04:59 PM ET

This chart shows the closing price history over time for JAZZ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Jazz Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2025Mary Elizabeth HendersonSVPSell2,238$169.51$379,363.3819,508View SEC Filing Icon  
12/5/2025Patricia CarrCAOSell4,660$171.20$797,792.007,012View SEC Filing Icon  
11/26/2025Bruce C. CozaddDirectorSell77,500$177.81$13,780,275.00393,332View SEC Filing Icon  
11/20/2025Heather Ann McSharryDirectorSell3,415$177.78$607,118.7020,449View SEC Filing Icon  
11/18/2025Bruce C. CozaddDirectorSell18,000$181.09$3,259,620.00390,826View SEC Filing Icon  
11/18/2025Patricia CarrCAOSell5,319$182.06$968,377.147,012View SEC Filing Icon  
11/18/2025Rick E. WinninghamDirectorSell5,500$180.86$994,730.008,893View SEC Filing Icon  
11/17/2025Robert IannoneEVPSell7,159$168.26$1,204,573.3472,628View SEC Filing Icon  
10/3/2025Bruce C. CozaddDirectorSell3,500$140.00$490,000.00408,826View SEC Filing Icon  
10/1/2025Bruce C. CozaddDirectorSell2,000$131.78$263,560.00412,326View SEC Filing Icon  
9/2/2025Bruce C. CozaddDirectorSell6,000$128.62$771,720.00429,973View SEC Filing Icon  
7/1/2025Bruce C. CozaddCEOSell1,000$107.63$107,630.00436,973View SEC Filing Icon  
6/2/2025Bruce C. CozaddCEOSell500$107.90$53,950.00438,473View SEC Filing Icon  
5/12/2025Seamus MulliganDirectorBuy1,621$103.00$166,963.00101,621View SEC Filing Icon  
5/9/2025Seamus MulliganDirectorBuy100,000$98.26$9,826,000.00100,000View SEC Filing Icon  
5/1/2025Bruce C. CozaddCEOSell1,000$116.35$116,350.00439,307View SEC Filing Icon  
4/1/2025Bruce C. CozaddCEOSell1,500$123.75$185,625.00440,307View SEC Filing Icon  
3/10/2025Patricia CarrCAOSell1,140$137.81$157,103.407,012View SEC Filing Icon  
3/10/2025Robert IannoneCMOSell2,403$138.41$332,599.2379,621View SEC Filing Icon  
3/7/2025Robert IannoneCMOSell7,080$138.60$981,288.0082,024View SEC Filing Icon  
3/3/2025Bruce C. CozaddCEOSell6,500$144.25$937,625.00464,058View SEC Filing Icon  
2/27/2025Neena M. PatilEVPSell3,800$144.87$550,506.0033,318View SEC Filing Icon  
2/27/2025Patricia CarrCAOSell4,813$144.42$695,093.468,237View SEC Filing Icon  
2/3/2025Bruce C. CozaddCEOSell1,500$122.31$183,465.00439,744View SEC Filing Icon  
1/2/2025Bruce C. CozaddCEOSell1,500$123.43$185,145.00425,525View SEC Filing Icon  
12/2/2024Bruce C. CozaddCEOSell2,000$121.17$242,340.00427,025View SEC Filing Icon  
12/2/2024Patricia CarrCAOSell53$122.49$6,491.976,596View SEC Filing Icon  
11/8/2024Neena M. PatilEVPSell3,700$123.41$456,617.0033,048View SEC Filing Icon  
11/1/2024Bruce C. CozaddCEOSell1,000$110.84$110,840.00428,976View SEC Filing Icon  
9/6/2024Mary Elizabeth HendersonSVPSell1,410$108.30$152,703.0014,531View SEC Filing Icon  
6/7/2024Patricia CarrCAOSell163$108.83$17,739.296,596View SEC Filing Icon  
5/3/2024Neena M. PatilEVPSell5,000$109.65$548,250.0036,629View SEC Filing Icon  
3/6/2024Patricia CarrCAOSell1,936$119.64$231,623.048,364View SEC Filing Icon  
3/1/2024Philip L. JohnsonCFOBuy12,000$119.65$1,435,800.0027,932View SEC Filing Icon  
12/4/2023Mark Douglas SmithDirectorSell417$119.27$49,735.596,888View SEC Filing Icon  
9/1/2023Neena M. PatilEVPSell1,500$144.25$216,375.0029,186View SEC Filing Icon  
8/29/2023Patricia CarrCAOSell142$143.47$20,372.745,986View SEC Filing Icon  
8/15/2023Neena M. PatilEVPSell750$139.59$104,692.5030,686View SEC Filing Icon  
8/14/2023Patricia CarrCAOSell158$138.16$21,829.286,128View SEC Filing Icon  
8/14/2023Rick E. WinninghamDirectorSell1,241$138.16$171,456.5610,444View SEC Filing Icon  
6/7/2023Patricia CarrCAOSell126$127.92$16,117.926,286View SEC Filing Icon  
6/1/2023Neena M. PatilEVPSell1,600$127.98$204,768.0032,826View SEC Filing Icon  
5/18/2023Renée D. GaláCFOSell6,000$131.75$790,500.0035,978View SEC Filing Icon  
3/15/2023Patricia CarrCAOSell1,023$133.22$136,284.066,286View SEC Filing Icon  
3/8/2023Kim SablichEVPSell3,013$139.74$421,036.6230,560View SEC Filing Icon  
3/7/2023Kenneth W. O'KeefeDirectorSell2,690$138.39$372,269.1022,889View SEC Filing Icon  
3/6/2023Finbar LarkinSVPSell1,706$143.92$245,527.5223,854View SEC Filing Icon  
3/5/2023Patricia CarrCAOSell1,148$140.76$161,592.487,309View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

89.14% of Jazz Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at JAZZ by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Jazz Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/4/2026Securian Asset Management Inc.4,443$0.76M0.0%-2.2%0.007%Search for SEC Filing on Google Icon
2/4/2026Twin Lakes Capital Management LLC1,554$0.26M0.1%-3.8%0.003%Search for SEC Filing on Google Icon
2/4/2026LRI Investments LLC221$38K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/3/2026Crossmark Global Holdings Inc.6,187$1.05M0.0%+68.4%0.010%Search for SEC Filing on Google Icon
2/3/2026Buck Wealth Strategies LLC7,876$1.34M0.2%+53.1%0.013%Search for SEC Filing on Google Icon
2/3/2026Sequoia Financial Advisors LLC3,987$0.68M0.0%-13.2%0.007%Search for SEC Filing on Google Icon
2/3/2026Praxis Investment Management Inc.1,430$0.24M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/3/2026Swedbank AB1,102,974$187.51M0.2%+2.7%1.815%Search for SEC Filing on Google Icon
2/2/2026Truist Financial Corp10,951$1.86M0.0%-66.5%0.018%Search for SEC Filing on Google Icon
2/2/2026Horizon Investments LLC10,831$1.84M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/2/2026Danske Bank A S400$68K0.0%+33.3%0.001%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer Asset Management Inc.9,371$1.59M0.0%-3.7%0.015%Search for SEC Filing on Google Icon
1/30/2026New York State Teachers Retirement System34,177$5.81M0.0%-1.9%0.056%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D19,947$3.39M0.0%-6.2%0.033%Search for SEC Filing on Google Icon
1/30/2026Innealta Capital LLC1,386$0.24M0.1%N/A0.002%Search for SEC Filing on Google Icon
1/30/2026Cardinal Capital Management14,538$2.47M0.3%+0.5%0.024%Search for SEC Filing on Google Icon
1/30/2026Bogart Wealth LLC550$94K0.0%+13,650.0%0.001%Search for SEC Filing on Google Icon
1/30/2026Mitsubishi UFJ Trust & Banking Corp41,166$7M0.0%-19.1%0.068%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp2,022$0.34M0.0%N/A0.003%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA184,696$31.49M0.0%-15.4%0.304%Search for SEC Filing on Google Icon
1/29/2026Inscription Capital LLC1,223$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG472,952$80.40M0.0%+2.9%0.778%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.5,917,142$1.01B0.0%+0.2%9.739%Search for SEC Filing on Google Icon
1/29/2026Polaris Capital Management LLC432,466$73.52M6.1%-15.8%0.712%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.9,902$1.68M0.1%-6.9%0.016%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System15,483$2.63M0.0%-9.0%0.025%Search for SEC Filing on Google Icon
1/28/2026HB Wealth Management LLC2,284$0.39M0.0%+11.0%0.004%Search for SEC Filing on Google Icon
1/28/2026Boston Trust Walden Corp393,911$66.97M0.5%-3.6%0.648%Search for SEC Filing on Google Icon
1/28/2026Ruffer LLP14,242$2.43M0.1%N/A0.023%Search for SEC Filing on Google Icon
1/28/2026M&T Bank Corp11,172$1.90M0.0%N/A0.018%Search for SEC Filing on Google Icon
1/28/2026Caliber Wealth Management LLC KS1,769$0.30M0.0%-18.8%0.003%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH90,089$15.32M0.0%+38.4%0.148%Search for SEC Filing on Google Icon
1/27/2026Optas LLC1,547$0.26M0.0%N/A0.003%Search for SEC Filing on Google Icon
1/27/2026Evergreen Capital Management LLC2,558$0.44M0.0%+17.7%0.004%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 228,642$38.87M0.1%+624.2%0.376%Search for SEC Filing on Google Icon
1/27/2026Graphene Investments SAS17,300$2.94M1.8%-35.4%0.028%Search for SEC Filing on Google Icon
1/27/2026Bayforest Capital Ltd1,450$0.25M0.2%-16.2%0.002%Search for SEC Filing on Google Icon
1/27/2026Lecap Asset Management Ltd.5,946$1.01M0.4%-5.9%0.010%Search for SEC Filing on Google Icon
1/27/2026GF Fund Management CO. LTD.1,194$0.20M0.0%-8.5%0.002%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.2,953$0.50M0.0%+25.9%0.005%Search for SEC Filing on Google Icon
1/26/2026CWM LLC5,100$0.87M0.0%+20.6%0.008%Search for SEC Filing on Google Icon
1/26/2026KBC Group NV103,338$17.57M0.0%+7.3%0.170%Search for SEC Filing on Google Icon
1/26/2026Generali Investments Towarzystwo Funduszy Inwestycyjnych1,050$0.18M0.1%-16.0%0.002%Search for SEC Filing on Google Icon
1/23/2026Farther Finance Advisors LLC657$0.11M0.0%+147.9%0.001%Search for SEC Filing on Google Icon
1/23/2026Assetmark Inc.10,848$1.84M0.0%+102.8%0.018%Search for SEC Filing on Google Icon
1/23/2026State of Alaska Department of Revenue42,012$7.14M0.1%-27.1%0.069%Search for SEC Filing on Google Icon
1/23/2026Burney Co.21,342$3.63M0.1%-4.1%0.035%Search for SEC Filing on Google Icon
1/23/2026Choreo LLC2,883$0.49M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/23/2026Sumitomo Mitsui Trust Group Inc.3,600$0.61M0.0%N/A0.006%Search for SEC Filing on Google Icon
1/23/2026Robeco Institutional Asset Management B.V.93,649$15.92M0.0%-2.9%0.154%Search for SEC Filing on Google Icon
1/23/2026Ritholtz Wealth Management21,614$3.67M0.1%+5.6%0.036%Search for SEC Filing on Google Icon
1/22/2026Massachusetts Financial Services Co. MA8,565$1.46M0.0%-3.2%0.014%Search for SEC Filing on Google Icon
1/22/2026Westbourne Investments Inc.1,400$0.24M0.1%N/A0.002%Search for SEC Filing on Google Icon
1/21/2026Prime Capital Investment Advisors LLC3,014$0.51M0.0%+17.8%0.005%Search for SEC Filing on Google Icon
1/21/2026Yousif Capital Management LLC12,813$2.15M0.0%+1.7%0.021%Search for SEC Filing on Google Icon
1/21/2026Aaron Wealth Advisors LLC2,979$0.51M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/21/2026Rathbones Group PLC1,349$0.23M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/21/2026Capricorn Fund Managers Ltd10,000$1.70M0.4%N/A0.016%Search for SEC Filing on Google Icon
1/20/2026Perpetual Ltd154,650$26.29M0.4%-74.3%0.255%Search for SEC Filing on Google Icon
1/20/2026Philip James Wealth Mangement LLC15,936$2.71M0.3%-0.6%0.026%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc60,337$10.26M0.0%-7.8%0.099%Search for SEC Filing on Google Icon
1/16/2026Kendall Capital Management8,304$1.41M0.3%-1.8%0.014%Search for SEC Filing on Google Icon
1/16/2026Blue Trust Inc.2,993$0.51M0.0%-8.2%0.005%Search for SEC Filing on Google Icon
1/16/2026Empirical Financial Services LLC d.b.a. Empirical Wealth Management4,532$0.77M0.0%+89.3%0.007%Search for SEC Filing on Google Icon
1/15/2026BTC Capital Management Inc.47,548$8.09M0.6%-8.1%0.078%Search for SEC Filing on Google Icon
1/15/2026Range Financial Group LLC7,772$1.32M0.5%-3.8%0.013%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC15,268$2.64M0.0%+10.6%0.025%Search for SEC Filing on Google Icon
1/15/2026Retirement Systems of Alabama167,698$28.51M0.1%-11.0%0.276%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.47,535$8.08M0.3%+25.5%0.078%Search for SEC Filing on Google Icon
1/14/2026Thompson Investment Management Inc.5,765$0.98M0.1%-12.3%0.009%Search for SEC Filing on Google Icon
1/14/2026Wedge Capital Management L L P NC188,878$32.11M0.6%-10.6%0.311%Search for SEC Filing on Google Icon
1/14/2026Exchange Traded Concepts LLC1,133$0.19M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/13/2026Fort Washington Investment Advisors Inc. OH1,200$0.20M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC136,024$23.12M0.0%+2,969.1%0.224%Search for SEC Filing on Google Icon
1/8/2026Sound View Wealth Advisors Group LLC8,796$1.50M0.1%-5.4%0.014%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC9,357$1.56M0.0%+51.5%0.015%Search for SEC Filing on Google Icon
1/7/2026MassMutual Private Wealth & Trust FSB353$60K0.0%-95.2%0.001%Search for SEC Filing on Google Icon
1/7/2026CWA Asset Management Group LLC20,742$3.53M0.1%-4.8%0.034%Search for SEC Filing on Google Icon
1/7/2026Hilltop National Bank210$36K0.0%N/A0.000%Search for SEC Filing on Google Icon
1/7/2026Sagespring Wealth Partners LLC1,411$0.24M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/5/2026Park Avenue Securities LLC6,081$1.03M0.0%+5.6%0.010%Search for SEC Filing on Google Icon
1/5/2026GoalVest Advisory LLC300$51K0.0%N/A0.000%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC1,012$0.17M0.0%+54.5%0.002%Search for SEC Filing on Google Icon
12/15/2025Mirabella Financial Services LLP1,848$0.24M0.0%N/A0.003%Search for SEC Filing on Google Icon
12/2/2025Swiss Life Asset Management Ltd2,692$0.36M0.0%N/A0.004%Search for SEC Filing on Google Icon
12/2/2025Goldentree Asset Management LP1,137,106$149.60M12.4%N/A1.871%Search for SEC Filing on Google Icon
12/1/2025Groupama Asset Managment2,576$0.34M0.0%-70.5%0.004%Search for SEC Filing on Google Icon
12/1/2025Cambria Investment Management L.P.5,889$0.78M0.0%+7.1%0.010%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.2,068$0.27M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/19/2025Faithward Advisors LLC27,904$3.68M0.5%+93.4%0.046%Search for SEC Filing on Google Icon
11/19/2025Sunbelt Securities Inc.400$53K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/19/2025Coldstream Capital Management Inc.4,472$0.59M0.0%+36.5%0.007%Search for SEC Filing on Google Icon
11/19/2025Danske Bank A S300$40K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd356$47K0.0%+1,383.3%0.001%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC900$0.12M0.0%-6.9%0.001%Search for SEC Filing on Google Icon
11/17/2025Krensavage Asset Management LLC167,816$22.12M9.4%+1.8%0.276%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co35,106$4.53M0.0%+0.5%0.058%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP264,968$34.92M0.2%+710.7%0.436%Search for SEC Filing on Google Icon
11/17/2025Dark Forest Capital Management LP11,540$1.52M0.0%-54.7%0.019%Search for SEC Filing on Google Icon
11/17/2025Alyeska Investment Group L.P.205,954$27.15M0.1%+1.0%0.339%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Jazz Pharmaceuticals logo
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.
Read More on Jazz Pharmaceuticals

Today's Range

Now: $165.70
Low: $165.86
High: $168.34

50 Day Range

MA: $168.58
Low: $160.25
High: $176.92

52 Week Range

Now: $165.70
Low: $95.49
High: $182.99

Volume

404,203 shs

Average Volume

1,122,918 shs

Market Capitalization

$10.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.26

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' top insider shareholders include:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
  3. Seamus Mulligan (Director)
  4. Robert Iannone (CMO)
  5. Robert Iannone (EVP)
  6. Neena M Patil (EVP)
  7. Philip L Johnson (CFO)
  8. Heather Ann Mcsharry (Director)
  9. Mary Elizabeth Henderson (SVP)
  10. Rick E Winningham (Director)
  11. Patricia Carr (CAO)
Learn More about top insider investors at Jazz Pharmaceuticals.

Who are the major institutional investors of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 9.74%
  2. Swedbank AB — 1.82%
  3. UBS Group AG — 0.78%
  4. Polaris Capital Management LLC — 0.71%
  5. Boston Trust Walden Corp — 0.65%
  6. Zurcher Kantonalbank Zurich Cantonalbank — 0.38%
Learn More about top institutional investors of Jazz Pharmaceuticals stock.

Which major investors are selling Jazz Pharmaceuticals stock?

Within the previous quarter, JAZZ stock was sold by these institutional investors:
  1. Perpetual Ltd
  2. Polaris Capital Management LLC
  3. Pictet Asset Management Holding SA
  4. Wedge Capital Management L L P NC
  5. Truist Financial Corp
  6. Retirement Systems of Alabama
  7. State of Alaska Department of Revenue
  8. Boston Trust Walden Corp
In the previous year, company insiders that have sold Jazz Pharmaceuticals company stock include:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
  3. Seamus Mulligan (Director)
  4. Robert Iannone (CMO)
  5. Robert Iannone (EVP)
  6. Neena M Patil (EVP)
  7. Philip L Johnson (CFO)
  8. Heather Ann Mcsharry (Director)
  9. Mary Elizabeth Henderson (SVP)
Learn More investors selling Jazz Pharmaceuticals stock.

Which major investors are buying Jazz Pharmaceuticals stock?

During the last quarter, JAZZ stock was acquired by institutional investors including:
  1. Zurcher Kantonalbank Zurich Cantonalbank
  2. SG Americas Securities LLC
  3. Swedbank AB
  4. Universal Beteiligungs und Servicegesellschaft mbH
  5. Ruffer LLP
  6. UBS Group AG
  7. M&T Bank Corp
  8. Horizon Investments LLC
During the last year, these company insiders have bought Jazz Pharmaceuticals stock:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
Learn More investors buying Jazz Pharmaceuticals stock.